AI assistant
Sending…
FENNEC PHARMACEUTICALS INC. — Director's Dealing 2023
Nov 9, 2023
35599_dirs_2023-11-09_601a0892-25b1-436a-9ffd-ed5d3123ced0.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: FENNEC PHARMACEUTICALS INC. (FENC)
CIK: 0001211583
Period of Report: 2023-11-08
Reporting Person: Raykov Rosty (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2023-11-08 | Common shares | S | 17049 | $7.69 | Disposed | 290582 | Direct |
| 2023-11-08 | Common shares | S | 7995 | $7.90 | Disposed | 282587 | Direct |
Footnotes
F1: Shares were the results of an option exercise on August 20, 2018, with a strike price of $1.44. Price of sold shares is an average.
F2: Shares were the results of options granted on November 20, 2012, with a strike price of $1.05. Price of sold shares is an average.
More from FENNEC PHARMACEUTICALS INC.
Regulatory Filings
2026
May 22
Regulatory Filings
2026
May 18
Interim / Quarterly Report
2026
May 14
Regulatory Filings
2026
Apr 28
Regulatory Filings
2026
Apr 7
Annual Report
2026
Mar 27
Regulatory Filings
2026
Mar 24
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Regulatory Filings
2026
Feb 20